Mode
Text Size
Log in / Sign up

Small cell carcinoma

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials for Small cell carcinoma

8 trials tracked for Small cell carcinoma.

8Trials tracked
0Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 2 8
  1. Phase 2 Study of Arsenic Trioxide in Small Cell Lung Cancer Completed
  2. Phase 2 Cisplatin and Etoposide With or Without Veliparib in Treating Patients With Extensive Stage Small Cell Lung Cancer Completed
  3. Phase 2 Safety and Efficacy Clinical Study of SNS-595 in Patients With Advanced Small Cell Lung Cancer Completed
  4. Phase 2 M7824 and Topotecan or Temozolomide in Relapsed Small Cell Lung Cancers Completed
  5. Phase 2 BI 2536 Second Line Monotherapy in SCLC Completed
  6. Phase 2 RRx-001 in Lung Cancer, Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT) Completed
Show 2 more trials
  1. Phase 2 Vinflunine in the Treatment of Patients With Relapsed Extensive Small Cell Lung Cancer Completed
  2. Phase 2 Topotecan and Carboplatin in the First-Line Treatment of Patients With Extensive Stage Small Cell Lung Cancer Completed

Showing the 8 most-cited and recently-updated of 8 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.